c-erbB-2 oncogene in breast cancer: The right target or a decoy?
- 1 September 1992
- journal article
- editorial
- Published by Elsevier in Human Pathology
- Vol. 23 (9) , 971-973
- https://doi.org/10.1016/0046-8177(92)90256-3
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Prognosis and Breast CancerThe American Journal of Surgical Pathology, 1991
- c-erbB-2 oncogene as a prognostic marker in breast cancerBritish Journal of Cancer, 1991
- Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situHuman Pathology, 1990
- NCL‐CB11, a new monoclonal antibody recognizing the internal domain of the c‐erbB‐2 oncogene protein effective for use on formalin‐fixed, paraffin‐embedded tissueThe Journal of Pathology, 1990
- 4. The role of the epidermal growth factor receptor and the c-erbB-2 protein in breast cancerInternational Journal of Cancer, 1990
- Neu-Protein Overexpression in Breast CancerNew England Journal of Medicine, 1988
- c-erbB-2 expression in benign and malignant breast diseaseBritish Journal of Cancer, 1988
- Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogeneCell, 1988
- OVEREXPRESSION OF THE c-erbB-2 ONCOPROTEIN IN HUMAN BREAST CARCINOMAS: IMMUNOHISTOLOGICAL ASSESSMENT CORRELATES WITH GENE AMPLIFICATIONThe Lancet, 1987
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987